Franklin Resources’s Terns Pharmaceuticals TERN Stock Holding History

Franklin Resources’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,409,019	Closed	-$127M	–	3332
2026 Q1	$127M	Sell	2,409,019 -322,293	-12%	-$13.2M	0.03%	379
2025 Q4	$110M	Buy	2,731,312 +1,453,849	+114%	+$33.6M	0.03%	409
2025 Q3	$9.59M	Buy	1,277,463 +67	+0%	+$428	﹤0.01%	1177
2025 Q2	$4.76M	Buy	+1,277,396	New	+$3.99M	﹤0.01%	1377
2024 Q3	–	Sell	-1,122,842	Closed	-$7.65M	–	3027
2024 Q2	$7.65M	Sell	1,122,842 -1,259,054	-53%	-$7.63M	﹤0.01%	1170
2024 Q1	$15.6M	Buy	2,381,896 +74,062	+3%	+$484K	﹤0.01%	939
2023 Q4	$15M	Buy	2,307,834 +159,013	+7%	+$841K	0.01%	829
2023 Q3	$10.8M	Buy	2,148,821 +664,167	+45%	+$4.21M	0.01%	898
2023 Q2	$13M	Buy	1,484,654 +27,200	+2%	+$317K	0.01%	869
2023 Q1	$17.3M	Buy	1,457,454 +707,430	+94%	+$6.76M	0.01%	814
2022 Q4	$7.64M	Buy	+750,024	New	+$4.99M	﹤0.01%	1011

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Franklin Resources's TERN Position: Q2 2026 in Review

Franklin Resources sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 2,409,019 shares — an estimated $127M sold.

Franklin Resources first reported a position in TERN in Q4 2022 and held it in 11 quarters. The position peaked at $127M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Franklin Resources reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Franklin Resources sold 2,409,019 Terns Pharmaceuticals shares in Q2 2026, an estimated $127M.
Franklin Resources first reported a position in Terns Pharmaceuticals in Q4 2022 and held it in 11 quarters.
Franklin Resources's Terns Pharmaceuticals position peaked at $127M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.